Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine

Abstract EN

Heart diseases are one of the leading causes of death in Western Countries and tend to become chronic, lowering the quality of life of the patients and ending up in a massive cost for the Health Systems and the society.

Thus, there is a growing interest in finding new technologies that would allow the physician to effectively treat and prevent cardiac illnesses.

Metabolomics is one of the new “omics” sciences enabling creation of a photograph of the metabolic state of an individual exposed to different environmental factors and pathologies.

This review analyzed the most recent literature about this technology and its application in cardiology in order to understand the metabolic shifts that occur even before the manifestation of these pathologies to find possible early predictive biomarkers.

In this way, it could be possible to find better treatments, ameliorate the patient’s quality of life, and lower the death rate.

This technology seems to be so promising that several industries are trying to set up kits to immediately assess the metabolites variations in order to provide a faster diagnosis and the best treatment specific for that patient, offering a further step toward the path of the development of a tailored medicine.